DPP-4 inhibitors (such as sitagliptin, linagliptin, or saxagliptin) enhance the body's own incretin system and are sulfonamide-free oral medications with a low risk of hypoglycaemia
After at least two years of treatment, GLP-1 users had a 37 percent higher chance of developing alopecia than patients taking SGLT-2 drugs and 68 percent higher odds than those taking DPP-4 drugs, both of which are also used to treat type 2 diabetes
Adverse hepatic outcomes related to NASH may include cirrhosis, liver failure and hepatocellular carcinoma, whereas non-liver-associated adverse outcomes are primarily related to increased cardiovascular disease and malignancy12,13
Robert Feldman: Well, in your model, you have a particular variable that captures the speed of diffusion
An increasing reactivity towards IAM due to deprotonation of one thiol set in between p H 4 and 4.5 (Fig
The effect of l-carnitine supplementation on serum levels of omentin-1, visfatin and SFRP5 and glycemic indices in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled clinical trial
